|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.84 USD | -0.42% |
|
-4.04% | -14.15% |
| 11-13 | Gene therapy developer Neurogene's Q3 net loss widens | RE |
| 11-13 | Neurogene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Chart calendar Neurogene Inc.
Upcoming events on Neurogene Inc.
| 14/01/2026 | JP Morgan Healthcare Conference | Add to your calendar Google Apple ICS format |
| 22/03/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 07/05/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 06/08/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 22/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Neurogene Inc.
| 13/11/2025 | Q3 2025 Earnings Release |
| 12/11/2025 | Stifel Healthcare Conference |
| 14/10/2025 | H.C. Wainwright Genetic Medicines Virtual Conference |
| 08/09/2025 | H.C. Wainwright Global Investment Conference |
| 12/08/2025 | Stifel Biotech Summer Summit |
| 11/08/2025 | Q2 2025 Earnings Release |
| 12/06/2025 | Annual General Meeting |
| 11/06/2025 | Goldman Sachs Global Healthcare Conference |
| 20/05/2025 | H.C. Wainwright BioConnect Investor Conference |
| 16/05/2025 | American Society of Gene & Cell Therapy Meeting |
| 15/05/2025 | American Society of Gene & Cell Therapy Meeting - Room 393-396 |
| 14/05/2025 | American Society of Gene & Cell Therapy Meeting |
| 08/05/2025 | Q1 2025 Earnings Release |
| 24/03/2025 | Q4 2024 Earnings Release |
| 19/03/2025 | Stifel Virtual CNS Forum |
| 10/03/2025 | Leerink Partners Global Healthcare Conference |
| 03/03/2025 | TD Cowen Healthcare Conference |
| 19/11/2024 | Stifel Healthcare Conference |
| 18/11/2024 | Q3 2024 Earnings Release |
| 12/11/2024 | Child Neurology Society Meeting |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,93 0,77 20% | 0,00 | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,6 -56,3 1.33% | -82,6 -83,3 0.81% | -104 | -121 | -143 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -53,6 32.24% | -75,1 -75,6 0.66% | -92,0 | -105 | -123 |
|
Net income Million USD | Released Forecast Spread | -55,2 | -36,3 -53,9 32.58% | -75,1 -77,3 2.77% | -91,1 | -115 | -135 |
|
EPS USD | Released Forecast Spread | -10,6 | -7,80 -5,58 -39.84% | -4,28 -4,35 1.5% | -4,28 | -5,12 | -6,36 |
| Announcement Date | 08/11/23 | 18/03/24 | 24/03/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,09 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,8 -15,3 -22.59% | -20,1 -19,9 -1.43% | -22,2 -22,2 0.24% | -21,5 -21,8 1.43% | -25,9 -21,8 -18.89% | -26,1 -26,8 2.59% | -23,8 -29,1 18.18% | -28,2 | -26,2 | -26,8 | -27,4 | -28,0 | -30,0 | -31,5 | -32,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,9 -13,8 -22.52% | -18,5 -17,3 -6.86% | -20,2 -21,2 4.81% | -19,5 -20,0 2.49% | -22,6 -20,1 -12.41% | -22,0 -24,5 10.05% | -21,0 -25,8 18.79% | -26,4 | -23,4 | -24,2 | -25,1 | -25,9 | -28,5 | -30,2 | -31,5 |
|
Net income Million USD | Released Forecast Spread | -16,9 -15,0 -13.04% | -18,5 -17,6 -5.06% | -20,2 -21,1 4.27% | -19,5 -21,6 9.81% | -22,6 -20,7 -9.54% | -22,0 -24,7 10.96% | -21,0 -27,0 22.51% | -25,4 | -23,4 | -24,2 | -25,1 | -25,9 | -28,5 | -30,2 | -31,5 |
|
EPS USD | Released Forecast Spread | -1,00 -0,95 -5.54% | -1,09 -1,03 -5.62% | -1,19 -1,22 2.59% | -0,99 -1,13 12.26% | -1,08 -1,06 -1.57% | -1,05 -1,16 9.48% | -0,99 -1,25 20.8% | -1,18 | -1,23 | -1,27 | -1,30 | -1,33 | -1,30 | -1,37 | -1,42 |
| Announcement Date | 10/05/24 | 09/08/24 | 18/11/24 | 24/03/25 | 09/05/25 | 11/08/25 | 13/11/25 | - | - | - | - | - | - | - | - |
| 19/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 21/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 27/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 02/02/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 03/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 08/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Neurogene Inc.
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 08/01/2026 | December 2025 Sales and Revenue Release | |
| 24/12/2025 | Q4 2025 Earnings Release | |
| 15/12/2025 | Q3 2025 Earnings Release | |
| 11/12/2025 | Q3 2025 Earnings Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release | |
| 09/12/2025 | Q3 2025 Earnings Release | |
| 21/11/2025 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NGNE Stock
- Calendar Neurogene Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















